Quarterly report pursuant to Section 13 or 15(d)

Other Balance Sheet Items (Tables)

v3.24.2.u1
Other Balance Sheet Items (Tables)
 9 Months Ended
Jun. 30, 2024
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]  
Schedule of Cash and Cash Equivalents
Table 10.1: Details of Cash and Cash Equivalents and Restricted Cash
June 30, 2024 September 30, 2023
(in thousands)
Cash and cash equivalents $ 102,794  $ 65,405 
Restricted cash 45,007  56,686 
Cash, cash equivalents, and restricted cash $ 147,801  $ 122,091 
Schedule of Restrictions on Cash and Cash Equivalents
Table 10.1: Details of Cash and Cash Equivalents and Restricted Cash
June 30, 2024 September 30, 2023
(in thousands)
Cash and cash equivalents $ 102,794  $ 65,405 
Restricted cash 45,007  56,686 
Cash, cash equivalents, and restricted cash $ 147,801  $ 122,091 
Schedule of Supplementary Cash Flow Information
Table 10.2: Supplemental Disclosures of Cash Flow Information
For the Nine Months Ended
June 30, 2024 June 30, 2023
(in thousands)
Interest payments $ 59,367  $ 59,580 
Income tax payments $ 67,822  $ 60,460 
Schedule of Details of Accounts Receivable
Table 10.3: Details of Accounts Receivable, Net
June 30, 2024 September 30, 2023
(in thousands)
Billed and billable receivables $ 613,429  $ 692,707 
Unbilled receivables 249,813  137,885 
Allowance for credit losses (12,780) (3,719)
Accounts receivable, net $ 850,462  $ 826,873